Colonics
 
About Me

Colonics resources

Recent Posts
Menu
Calendar
«  May 2012  »
MonTueWedThuFriSatSun
 123456
78910111213
14151617181920
21222324252627
28293031 

Friends
    Links


    Entry 1 of 2380
    Last Page | Next Page
    6/25/2011 - Analysis Provides New Insights Into Use Of SYMLIN® In Patients With Type 1 Diabetes Using Insulin Pumps
    Posted in Medical News

    Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) announced data from a new dissection characterizing the effects of SYMLIN® (pramlintide acetate) injection in billet with type 1 insulin-dependent insulin-dependent diabetes mellitus mellitus who used insulin pumps during two time was completed clinical studies. The data, which will be presented during a poster introduction at the 71st Scientific Sessions of the old glory insulin-dependent insulin-dependent diabetes mellitus mellitus troops (ADA) in San Diego, demonstrated that SYMLIN helped reduce A1C (a measure of average blood sugar over three months), insulin use and body weight in work with type 1 type i insulin-dependent diabetes mellitus who used insulin pumps...



    More: - From the site

    Share |


    Technorati Tags:
    Filed under:

    Post A Comment! :: Send to a Friend!

    Notify me of followup comments via e-mail.

    Share and enjoy
    • Digg
    • del.icio.us
    • DZone
    • Netvouz
    • NewsVine
    • Reddit
    • Slashdot
    • StumbleUpon
    • Technorati
    • YahooMyWeb